Bailard, Inc.
- SEC CIK
- 0000750641
- Latest filing
- Jul 30, 2026
CGEM holding history
Cullinan Therapeutics, Inc. in every 13F filed by Bailard, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CGEM overviewAll 13F holders of CGEMFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −10,800−100.0% | Sold out | Holders |
| Q4 2023 | 10,800 | $110.1K | <0.1% | +10,800 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −11,000−100.0% | Sold out | Holders |
| Q1 2023 | 11,000 | $112.5K | <0.1% | +11,000 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −9,600−100.0% | Sold out | Holders |
| Q3 2021 | 9,600 | $217.0K | <0.1% | +9,600 | New | Holders |